Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

New quinolone from Bayer undergoing extensive evaluation

Sep. 20, 1996

Antiinfective drugs in development at Daiichi

Sep. 13, 1996

Antiinfective R&D at Toyama

Sep. 13, 1996

Antirhinovirus compounds from Lilly

Sep. 13, 1996

Antibacterial 2-pyridones, a novel class of DNA gyrase inhibitors

Sep. 13, 1996

Merck & Co. discloses novel antifungal agent

Sep. 13, 1996

Natural antibacterial agent reported by Korean researchers

Sep. 13, 1996

Antibacterial agents disclosed by Hokuriku

Sep. 13, 1996

Virus susceptibility gene finally cloned

Sep. 6, 1996

Thalidomide effective in chronic erythema multiforme

Sep. 6, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Elixirgen and Nippon Shinyaku sign EXG-7001 option agreement
BioWorld Science
Elixirgen Therapeutics Inc. has entered into an option agreement with Nippon Shinyaku Co. Ltd. for the development and commercialization of EXG-7001 for Duchenne...
Investors bet on transformative BCI tech for neuro disorders
BioWorld
An estimated $2 billion has been invested in the brain-computer interface (BCI) space in the last two years and the level of funding is expected to continue....